WHAT OUR CLIENTS SAY

We are developing a late-stage drug in a competitive field where the science is evolving rapidly. Dave and Zoia were able, in a short time, to grasp the most compelling aspects of our story including the science and clinical product profile, and translated them into clear, concise messaging that resonated with the medical community, media and the public. In my experience at large pharma and biotech startups, Tager&Co. stands out as a valued, strategic resource that is remarkably productive. They’ve helped us build an effective communication strategy for our various stakeholders. It is a pleasure working with such talent.” 

The past 18 months have been transformational, including the way we communicate. While the media has been covering the COVID pandemic, getting them to consider any story outside their focus needs a new approach, persistence, an extensive and reliable network and trust. Tager&Co. has all these attributes as well as a strategic approach to getting traction with media outlets. They have worked with us since early 2020 to transmit the conceptual framework of our efforts in COVID-19, the evidence being generated on the science and clinical front as well as the relevance of the data. Through their efforts we have received national coverage at various venues. Dave provides exceptional help in preparing for interviews and then uses these media interactions to create additional future opportunities. We are very grateful to Dave and his team for their partnership.”

When Year Up started working with Dave over a decade ago, we were in three cities, serving a couple of hundred young adults, with an operating budget under $10 million. Today, we are a $150 million company, helping thousands of young people in over 20 cities across the country. Dave and his team’s media results — the 60 Minutes profile, regular stories in the New York Times and Wall Street Journal, interviews on CNBC and with other top outlets — have been major contributors to Year Up’s growth and success in advancing our mission. Beyond PR, Tager’s connections to senior executives at companies such as US Bank and Citadel have led to enduring, valuable corporate partnerships."

We hired Tager&Co. to help promote Brain Chemistry Labs’ milestone achievements for Alzheimer’s and ALS research. Their outstanding PR initiatives yielded us tremendous press coverage, including a 12-page cover story in Fortune magazine. A feature story like this is unprecedented for an organization of our size and a game-changer that will help attract substantial financial support for years to come.”

When Crown Global wanted to build its institutional business, we turned to Tager&Co. They quickly identified the issues that would resonate with our prospects: trustees and chief investment officers at large foundations and endowments. They worked with me to develop a bylined article, got it published immediately, and then turned that into a marketing piece that has since served as terrific door-opener, and clearly sets us apart from the competition. Dave is always thinking about our success, and he regularly makes introductions to potential clients and referral sources.”

Year after year, Tager gets us amazing media results. Their writing is impeccable and almost instantaneous. They’re not just super responsive to our requests, they’re a strategic thought partner always delivering innovative ideas. We know they have other clients, but we’ve never felt that way.”

Tager&Co.’s ability to understand and communicate our products and services helped us broaden our target markets.”

I’ve worked with a dozen PR firms over my career in healthcare and biotech, and it was like they were just throwing spaghetti against the wall to see what would stick. Tager&Co. is in a different category. They’re smart and strategic, and they see the long game. ... The week we announced the launch of our company, Dave got us a cover story in the Boston Globe, a CBS segment, an article in Seattle Times, and coverage in all our key biopharma trades. At the time, we had less than a handful of employees and a 30-year old drug that we’d just acquired. From my past experience with the Tager team, this wasn’t a surprise. They always get the best results.”